| pubmed-article:9246278 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9246278 | lifeskim:mentions | umls-concept:C0010031 | lld:lifeskim |
| pubmed-article:9246278 | lifeskim:mentions | umls-concept:C0022563 | lld:lifeskim |
| pubmed-article:9246278 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:9246278 | lifeskim:mentions | umls-concept:C1691013 | lld:lifeskim |
| pubmed-article:9246278 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
| pubmed-article:9246278 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:9246278 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9246278 | pubmed:dateCreated | 1997-8-21 | lld:pubmed |
| pubmed-article:9246278 | pubmed:abstractText | We investigated an individual macular corneal dystrophy (MCD) type II cornea from a 42-year-old woman with markedly reduced antigenic keratan sulphate levels. A characteristic 4.6 A X-ray reflection was evident, and the mid-stroma contained 30% less sulphur than normal. Close packing of collagen was restricted to the superficial stroma. Abnormally large proteoglycan filaments were noted throughout the extracellular matrix and Descemet's membrane's posterior non-banded zone, but not its anterior banded zone. Small, collagen-associated stromal proteoglycans were susceptible to digestion with chondroitinase ABC, but not keratanase I or N-glycanase. On occasion, collagen fibrils ranged in size from 20 nm to 58 nm, with preferential diameters of 34 nm and 42 nm. Corneal guttae were evident, as were numerous endothelial inclusions, most probably due to intracellular fibrillogranular vacuoles similar to those found in the stroma. The endothelium expressed reduced anti-keratan sulphate labelling. | lld:pubmed |
| pubmed-article:9246278 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9246278 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9246278 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9246278 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9246278 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9246278 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9246278 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9246278 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9246278 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9246278 | pubmed:issn | 0950-222X | lld:pubmed |
| pubmed-article:9246278 | pubmed:author | pubmed-author:ItoMM | lld:pubmed |
| pubmed-article:9246278 | pubmed:author | pubmed-author:WaltmanS RSR | lld:pubmed |
| pubmed-article:9246278 | pubmed:author | pubmed-author:ThonarE JEJ | lld:pubmed |
| pubmed-article:9246278 | pubmed:author | pubmed-author:SchanzlinD... | lld:pubmed |
| pubmed-article:9246278 | pubmed:author | pubmed-author:VerityS MSM | lld:pubmed |
| pubmed-article:9246278 | pubmed:author | pubmed-author:FullwoodN JNJ | lld:pubmed |
| pubmed-article:9246278 | pubmed:author | pubmed-author:QuantockA JAJ | lld:pubmed |
| pubmed-article:9246278 | pubmed:author | pubmed-author:CapelM SMS | lld:pubmed |
| pubmed-article:9246278 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9246278 | pubmed:volume | 11 ( Pt 1) | lld:pubmed |
| pubmed-article:9246278 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9246278 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9246278 | pubmed:pagination | 57-67 | lld:pubmed |
| pubmed-article:9246278 | pubmed:dateRevised | 2009-11-3 | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:meshHeading | pubmed-meshheading:9246278-... | lld:pubmed |
| pubmed-article:9246278 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9246278 | pubmed:articleTitle | Macular corneal dystrophy type II: multiple studies on a cornea with low levels of sulphated keratan sulphate. | lld:pubmed |
| pubmed-article:9246278 | pubmed:affiliation | Anheuser-Busch Eye Institute, Department of Ophthalmology, Saint Louis University School of Medicine, Missouri, USA. | lld:pubmed |
| pubmed-article:9246278 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9246278 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9246278 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:9246278 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:9246278 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
